Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma
Acta Biomaterialia · 2026-08 · 219 · 278-294
DOI: 10.1016/j.actbio.2026.07.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-08. Verfasst von Jiaju Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Sunitinib, Carcinoma, Renal Cell, Gelatin, Hydrogels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Province Natural Science Foundation, China Postdoctoral Science Foundation, Zhejiang Province Science and Technology Department.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: caiming@zju.edu.cn.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wangbohan@zju.edu.cn.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wenjiaming@zju.edu.cn.
Förderung
- Zhejiang Province Natural Science Foundation
- China Postdoctoral Science Foundation
- Zhejiang Province Science and Technology Department
- National Natural Science Foundation of China
Zitieren
APA
Xu, J., Xu, J., Shu, Y., Huangfu, Q., Shen, L., Wei, J., He, X., Sun, C., Chen, J., Tang, L., Meng, L., Wang, W., Cai, M., Wang, B., & Wen, J. (2026). Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta Biomaterialia, 219, 278-294. https://doi.org/10.1016/j.actbio.2026.07.001
Vancouver
Xu J, Xu J, Shu Y, Huangfu Q, Shen L, Wei J, et al. Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta Biomaterialia. 2026;219:278-294. doi:10.1016/j.actbio.2026.07.001
BibTeX
@article{Xu2026,
author = {Xu, Jiaju and Xu, Jinming and Shu, Yichang and Huangfu, Qi and Shen, Letian and Wei, Jingchao and He, Xuhong and Sun, Chengfang and Chen, Juntao and Tang, Linsong and Meng, Longxiyu and Wang, Weikai and Cai, Ming and Wang, Bohan and Wen, Jiaming},
title = {Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma},
journal = {Acta Biomaterialia},
year = {2026},
volume = {219},
pages = {278--294},
doi = {10.1016/j.actbio.2026.07.001}
}
EUVIMED